02348 DAWNRAYS PHARMA
Trading Add to Porfolio| Key Financial Ratio (Fiscal Year: 12/2024) | |||
| Current | 3.97X | Oper Margin | 60.8% |
|---|---|---|---|
| LT Debt/Equity | 0.1% | Net Margin | 53.3% |
| Total Debt/Equity | 1.0% | Return on Equity | 17.0% |
| Price/Book | 0.53X | Return on Assets | 14.1% |
| (HKD 1.250) | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
| Net Profit (MHKD) | 600.81 | 359.32 | 401.45 | 438.08 | 318.22 |
|---|---|---|---|---|---|
| Net Profit Growth (%) | +67.2 | -10.5 | -8.4 | +37.7 | +11.4 |
| Earnings Per Share (HKD) | 0.399 | 0.24 | 0.268 | 0.293 | 0.206 |
| Earnings Per Share Growth (%) | +66.6 | -10.6 | -8.4 | +42.0 | +13.6 |
| Dividend Per Share (HKD) | 0.095 | 0.080 | 0.088 | 0.080 | 0.115 |
| P/E* (X) | 3.13 | 5.22 | 4.67 | 4.27 | 6.07 |
| Yield (%) | 7.60 | 6.40 | 7.04 | 6.40 | 9.20 |
| Dividend Share (%) | 23.80 | 33.39 | 32.85 | 27.35 | 55.83 |
| Book NAV (HKD) | 2.354 | 2.097 | 1.976 | 1.943 | 1.700 |
| Auditors' Opinion | Unqualified | Unqualified | Unqualified | Unqualified | Unqualified |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2025-09-07 21:40:22
Latest Result
| (RMBMn) | 2025-06 | 2024-06 | Chg* (%) | 2023-06 |
| Cover Period (mths) | 6 | 6 | NA | 6 |
|---|---|---|---|---|
| Turnover | 630.424 | 577.447 | +9.2 | 649.92 |
| Operating Result | 130.317 | 273.778 | -52.4 | 347.509 |
| Associates | 0 | -3.696 | -100.0 | -20.298 |
| Profit Before Taxation | 130.317 | 556.752 | -76.6 | 327.211 |
| Taxation | 28.609 | 65.169 | -56.1 | 73.041 |
| Profit /( Loss) After Taxation | 101.708 | 491.583 | -79.3 | 254.17 |
| Minority Interests | -2.864 | -1.463 | +95.8 | -1.771 |
| Net Profit | 104.572 | 493.046 | -78.8 | 255.941 |
| Earnings Per Share () | 0.0763 | 0.3532 | -78.4 | 0.1842 |
| Dividend Per Share () | 0.0150 | 0.0150 | +0.0 | 0.0150 |
| Announcement Date | 2025-08-22 | 2024-08-23 | NA | 2023-08-25 |
* Annualised
Last Update Time: 2025-09-07 21:40:27
